Reactions of ruthenium silylene complexes of the type [Cp*(PMe 3 ) 2 Ru SiR 2 ] + with unsaturated compounds were investigated. Nonpolar, unsaturated substrates such as ethylene, acetylene, and 2-butyne do not react with [Cp*(PMe 3 ) 2 Ru SiR 2 ]B(C 6 F 5 ) 4 ( 1a, R = Me; 1b, R = Ph). However, methyl isocyanate inserts into an Si−S bond of the silylene complex [Cp*(PMe 3 ) 2 Ru Si(STol) 2 ][BPh 4 ] ( 5 ) to give the 1,2-dipolar addition product {Cp*(PMe 3 ) 2 RuSi(STol)[η 2 −O(MeN)C(STol)]}[BPh 4 ] ( 6a ) in 87% yield. This product was characterized by X-ray crystallography as possessing a base-stabilized silylene ligand with thiolate and thiocarbamate substituents. Compound 1a reacts with methyl and phenyl isocyanate to give the 2 + 2 R = Me; 8, R = Ph). The analogous triflate R = Ph; 10, R = Me) were prepared by reaction of the appropriate ruthenium silyls Cp*(PMe 3 ) 2 RuSiR 2 OTf with methyl isocyanate. Heating 9 to 100 °C in toluene resulted in dissociation of the isocyanate and regeneration of the triflate Cp*(PMe 3 ) 2 RuSiPh 2 OTf. Competition reactions of various para-substituted phenyl isocyanates with 1b show that the rate of cycloaddition increases with the electron-donating ability of the incoming isocyanate. This is consistent with a stepwise cycloaddition mechanism involving initial coordination of the isocyanate nitrogen atom to the Lewis acidic silylene silicon atom.
No takes yet. Share an insight, caveat, or question.
Mitchell et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: